logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Guowen Yin

nanjing medical university
H指数:19
被引数:3,067

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)

使用影像生物标志物解码肿瘤异质性可预测TACE联合免疫治疗和靶向治疗在HCC中的疗效（CHANCE2204）

HEPATOLOGY
IF15.8
2025-11-013
PRE
Jin, Zhi-Cheng; Wei, Jingwei; Xiao, Yu-Dong; Si, Anfeng; Chen, Jian-Jian; Zhu, Xiao-Li; Li, Jin-Ze; Nie, Fang; Ding, Rong; Zhou, Hai-Feng; Ding, Wei; Zhong, Bin-Yan; Xie, Yangyang; Hu, Hong-Tao; Yin, Guo-Wen; Ji, Jian-Song; Zhang, Wei-Hua; Shi, Hai-Bin; Wu, Jian-Bing; Xu, Guo-Hui; Yuan, Chun-Wang; Yang, Wei-Zhu; Liu, Rui-Bao; Wu, Ye-Ming; Zheng, Chuan-Sheng; Xu, Ai-Bing; Huang, Ming-Sheng; Li, Jia-Ping; Chen, Li; Wen, Shu-Wei; Wang, Yu-Qing; Gu, Shan-Zhi; Li, Dongrui; Wang, Duo; Zhou, Guan-Hui; Wang, Wei-Dong; Peng, Zhenwei; Wang, Xinying; Zhu, Hai-Dong; Tian, Jie; Teng, Gao-Jun
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations

中国肝细胞癌的动脉化疗: 共识建议

HEPATOLOGY INTERNATIONAL
IF6.1
2023-10-2123
PRE
Zhao, Ming; Guo, Zhi; Zou, Ying-Hua; Li, Xiao; Yan, Zhi-Ping; Chen, Min-Shan; Fan, Wei-Jun; Li, Hai-Liang; Yang, Ji-Jin; Chen, Xiao-Ming; Xu, Lin-Feng; Zhang, Yue-Wei; Zhu, Kang-Shun; Sun, Jun-Hui; Li, Jia-Ping; Jin, Yong; Yu, Hai-Peng; Duan, Feng; Xiong, Bin; Yin, Guo-Wen; Lin, Hai-Lan; Ma, Yi-Long; Wang, Hua-Ming; Gu, Shan-Zhi; Si, Tong-Guo; Wang, Xiao-Dong; Zhao, Chang; Yu, Wen-Chang; Guo, Jian-Hai; Zhai, Jian; Huang, Yong-Hui; Wang, Wei-Yu; Lin, Hai-Feng; Gu, Yang-Kui; Chen, Jin-Zhang; Wang, Jian-Peng; Zhang, Yi-Min; Yi, Jun-Zhe; Lyu, Ning
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2023-06-229
PRE
Lei, Zhengqing; Ma, Weihu; Si, Anfeng; Zhang, Yuhua; Yang, Facai; Yu, Qiushi; Tang, Haolan; Xiao, Qianru; Zhou, Jiahua; Wang, Kui; Tang, Yufu; Han, Tao; Yin, Guowen; Chen, Jinhong; Liu, Xiufeng; Zhao, Hua; Yu, Decai; Luo, Tao; Wang, Qing; Yan, Maolin; Mao, Xianhai; Li, Jing; Wang, Kai; Li, Jingdong; Zeng, Yongyi; Ding, Dequan; Chen, Tingsong; Wu, Xiaofeng; Xia, Yongxiang; Wang, Kang; Guo, Weixing; Zhu, Guangyu; Gao, Shan; Hueser, Norbert; Lau, Wan Y.; Song, Tianqiang; Cheng, Shuqun; Shen, Feng; Cheng, Zhangjun
Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial
INTERNATIONAL JOURNAL OF SURGERY
IF10.1
2023-05-0114
OAAI
Lu, Jian; Guo, Jin-He; Ji, Jian-Song; Li, Yu-Liang; Lv, Wei-Fu; Zhu, Hai-Dong; Sun, Jun-Hui; Ren, Wei-Xin; Zhang, Fu-Jun; Wang, Wei-Dong; Shao, Hai-Bo; Cao, Guang-Shao; Li, Hai-Liang; Gao, Kun; Yang, Po; Yin, Guo-Wen; Zhu, Guang-Yu; Wu, Fa-Zong; Wang, Wu-Jie; Lu, Dong; Chen, Sheng-Qun; Min, Jie; Zhao, Yang; Li, Rui; Lu, Li-Gong; Lau, Wan Yee; Teng, Gao-Jun
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A for Nonrandomized, Open-label, Phase II Trial

Camrelizumab联合阿帕替尼治疗晚期肝细胞癌 (RESCUE): 非随机，开放标签，II期试验

CLINICAL CANCER RESEARCH
IF10.2
2021-02-15475
OAAI
Xu, Jianming; Shen, Jie; Gu, Shanzhi; Zhang, Yun; Wu, Lihua; Wu, Jian; Shao, Guoliang; Zhang, Yanqiao; Xu, Li; Yin, Tao; Liu, Jingfeng; Ren, Zhenggang; Xiong, Jianping; Mao, Xianhai; Zhang, Ling; Yang, Jiayin; Li, Lequn; Chen, Xiaoming; Wang, Zhiming; Gu, Kangsheng; Chen, Xi; Pan, Zhanyu; Ma, Kuansheng; Zhou, Xinmin; Yu, Zujiang; Li, Enxiao; Yin, Guowen; Zhang, Xiao; Wang, Shuni; Wang, Quanren
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
LIVER CANCER
IF9.1
2020-02-1918
OAAI
Wang, Zhexuan; Wang, Enxin; Bai, Wei; Xia, Dongdong; Ding, Rong; Li, Jiaping; Wang, Qiuhe; Liu, Lei; Sun, Junhui; Mu, Wei; Zhao, Hui; Pan, Xingnan; Shao, Guoliang; Zhu, Xiaoli; Yin, Guowen; Shi, Haibin; Wu, Jianbing; Lin, Zhengyu; Yang, Shufa; Liu, Jueshi; Wang, Wenhui; Zhu, Xu; Lv, Yong; Li, Jing; Chen, Hui; Wang, Wenjun; Li, Kai; Yuan, Xulong; Yu, Tanlei; Yuan, Jie; Li, Xiaomei; Niu, Jing; Yin, Zhanxin; Xia, Jielai; Fan, Daiming; Han, Guohong
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study

开发推荐的肝细胞癌TACE候选者的预后评分: 一项多中心观察性研究

JOURNAL OF HEPATOLOGY
IF33
2019-05-01188
PREAI
Wang, Qiuhe; Xia, Dongdong; Bai, Wei; Wang, Enxin; Sun, Junhui; Huang, Ming; Mu, Wei; Yin, Guowen; Li, Hailiang; Zhao, Hui; Li, Jing; Zhang, Chunqing; Zhu, Xiaoli; Wu, Jianbing; Li, Jiaping; Gong, Weidong; Li, Zixiang; Lin, Zhengyu; Pan, Xingnan; Shi, Haibin; Shao, Guoliang; Liu, Jueshi; Yang, Shufa; Zheng, Yanbo; Xu, Jian; Song, Jinlong; Wang, Wenhui; Wang, Zhexuan; Zhang, Yuelin; Ding, Rong; Zhang, Hui; Yu, Hui; Zheng, Lin; Gu, Weiwei; You, Nan; Wang, Guangchuan; Zhang, Shuai; Feng, Long; Liu, Lin; Zhang, Peng; Li, Xueda; Chen, Jian; Xu, Tao; Zhou, Weizhong; Zeng, Hui; Zhang, Yongjin; Huang, Wukui; Jiang, Wenjin; Zhang, Wen; Shao, Wenbo; Li, Lei; Niu, Jing; Yuan, Jie; Li, Xiaomei; Lv, Yong; Li, Kai; Yin, Zhanxin; Xia, Jielai; Fan, Daiming; Han, Guohong
Identifying optimal candidates for combining transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma: A multicenter observational study
JOURNAL OF HEPATOLOGY
IF33
2019-04-010
PREAI
Wang, Enxin; Bai, Wei; Wang, Zhexuan; Xia, Dongdong; Wang, Qiuhe; Huang, Ming; Sun, Junhui; Mu, Wei; Zhao, Hui; Pan, Xingnan; Shao, Guoliang; Zhu, Xiaoli; Yin, Guowen; Shi, Haibin; Wu, Jianbing; Li, Jiaping; Lin, Zhengyu; Yang, Shufa; Liu, Jueshi; Wang, Wenhui; Zhu, Xu; Ding, Rong; Lv, Yong; Chen, Hui; Li, Kai; Niu, Jing; Yin, Zhanxin; Xia, Jielai; Fan, Daiming; Han, Guohong
Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization
JOURNAL OF HEPATOLOGY
IF33
2019-04-010
PREAI
Xia, Dongdong; Wang, Enxin; Wang, Qiuhe; Bai, Wei; Wang, Zhexuan; Mu, Wei; Sun, Junhui; Huang, Ming; Yin, Guowen; Li, Hailiang; Zhao, Hui; Zhang, Chunqing; Li, Jing; Wu, Jianbing; Zhu, Xiaoli; Yang, Shufa; Pan, Xingnan; Li, Jiaping; Li, Zixiang; Xu, Guohui; Shi, Haibin; Wang, Wenjun; Niu, Jing; Yuan, Jie; Li, Xiaomei; Lv, Yong; Li, Kai; Yin, Zhanxin; Fan, Daiming; Xia, Jielai; Han, Guohong

研究方向

暂未获取到该数据
Q
Qingyu Xu
H 指数:24论文数:145被引数:1,757
R
Ran You
H 指数:19论文数:116被引数:2,084
J
Jiaping Li
H 指数:41论文数:351被引数:6,974
J
Jianbing Wu
H 指数:20论文数:93被引数:2,864
X
Xiaoli Zhu
H 指数:0论文数:0被引数:0
G
Guohong Han
H 指数:54论文数:293被引数:1.9万
Y
Yong Lv
H 指数:26论文数:143被引数:2,571
H
Hai‐Bin Shi
H 指数:32论文数:307被引数:4,060
Z
Zhexuan Wang
H 指数:14论文数:61被引数:903
J
Junhui Sun
H 指数:24论文数:102被引数:2,452